Literature DB >> 30160147

Time-course of transcriptome response to respiratory syncytial virus infection in lung epithelium cells.

S Ampuero, R Andaur, M Milano, M Moreno, L Lizama, C Larrañaga, U Urzúa.   

Abstract

Respiratory syncytial virus (RSV) is the major cause of acute lower respiratory tract infection in infants. Winter outbreaks in Chile result in 5% of infected children hospitalized, with 0.01% mortality. Increased evidence indicates that viral and host factors modulate the severity of infection. Using DNA microarrays, we characterized the genome-wide transcriptional response of lung mucoepidermoid cells (NCI-H292) at 0, 24, 48, 72 and 96 hours post-infection (hpi) with a single dose of RSV/A. During the whole studied period, a bi-phasic gene expression profile was observed by a total of 330 differentially expressed genes. About 60% of them were up-regulated between 24-72 hpi and then turned-off at 96 hpi. This transient, early gene expression pattern was significantly enriched in biological processes like interferon signaling, antigen processing and presentation, double-stranded RNA binding and chemokine activity. We detected 27 common genes up-regulated between 24-72 hpi, from which IFIT1, IFI44, MX1, CXCL11 and OAS1 had the highest expression. The second pattern comprised over 120 genes, which remained silenced until 72 hpi, but were steeply up-regulated by 96 hpi. Biological processes of this late-response profile included cell cycle division and microtubule cytoskeleton organization. Conversely, the genes belonging to virus response pathway showed a decreased expression at 96 hpi. We conclude that RSV induces an early innate immune activation profile response until 72 hpi. Thereafter, the viral response is inhibited, leading to host cell recovery. The presented cellular model allows to study the specific pathways involved in elimination of infection at prolonged time intervals and their subsequent analysis in severe RSV disease of infants and/or older adults.

Entities:  

Keywords:  RSV; NCI-H292 cells; microarrays; time-course; gene expression profile.

Mesh:

Year:  2018        PMID: 30160147     DOI: 10.4149/av_2018_225

Source DB:  PubMed          Journal:  Acta Virol        ISSN: 0001-723X            Impact factor:   1.162


  5 in total

1.  Human Respiratory Syncytial Virus-Induced Immune Signature of Infection Revealed by Transcriptome Analysis of Clinical Pediatric Nasopharyngeal Swab Samples.

Authors:  Claire Nicolas De Lamballerie; Andrés Pizzorno; Julia Dubois; Blandine Padey; Thomas Julien; Aurélien Traversier; Julie Carbonneau; Elody Orcel; Bruno Lina; Marie-Eve Hamelin; Magali Roche; Julien Textoris; Guy Boivin; Catherine Legras-Lachuer; Olivier Terrier; Manuel Rosa-Calatrava
Journal:  J Infect Dis       Date:  2021-03-29       Impact factor: 5.226

2.  Balancing precision versus cohort transcriptomic analysis of acute and recovery phase of viral bronchiolitis.

Authors:  Ruchir Gupta; Mara L Leimanis; Marie Adams; André S Bachmann; Katie L Uhl; Caleb P Bupp; Nicholas L Hartog; Eric J Kort; Rosemary Olivero; Sarah S Comstock; Dominic J Sanfilippo; Sophia Y Lunt; Jeremy W Prokop; Surender Rajasekaran
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2021-04-14       Impact factor: 6.011

3.  Microbiome-Transcriptome Interactions Related to Severity of Respiratory Syncytial Virus Infection.

Authors:  Abhijeet R Sonawane; Liang Tian; Chin-Yi Chu; Xing Qiu; Lu Wang; Jeanne Holden-Wiltse; Alex Grier; Steven R Gill; Mary T Caserta; Ann R Falsey; David J Topham; Edward E Walsh; Thomas J Mariani; Scott T Weiss; Edwin K Silverman; Kimberly Glass; Yang-Yu Liu
Journal:  Sci Rep       Date:  2019-09-25       Impact factor: 4.379

4.  Mutation of Respiratory Syncytial Virus G Protein's CX3C Motif Attenuates Infection in Cotton Rats and Primary Human Airway Epithelial Cells.

Authors:  Binh Ha; Tatiana Chirkova; Marina S Boukhvalova; He Ying Sun; Edward E Walsh; Christopher S Anderson; Thomas J Mariani; Larry J Anderson
Journal:  Vaccines (Basel)       Date:  2019-07-19

5.  Analysis of lung transcriptome in calves infected with Bovine Respiratory Syncytial Virus and treated with antiviral and/or cyclooxygenase inhibitor.

Authors:  Maxim Lebedev; Heather A McEligot; Victoria N Mutua; Paul Walsh; Francisco R Carvallo Chaigneau; Laurel J Gershwin
Journal:  PLoS One       Date:  2021-02-18       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.